AstraZeneca could buy Bristol stake in diabetes JV -analyst
November 08, 2013 at 05:32 AM EST
LONDON, Nov 8 (Reuters) - AstraZeneca may seek to increase its stake in a diabetes joint venture with Bristol-Myers Squibb, following a decision by the U.S. firm to exit diabetes drug research, according to Citi.
